Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…Exploring the Feasibility of Telerehabilitation for Balance Deficits in People with PD; the TelePD Trial
Objective: To evaluate the feasibility of adapting our Agility Boot Camp (ABC) for balance telerehabilitation (Tele-ABC) in people with mild-to-moderate Parkinson’s disease (PD). Background: Balance impairments…Hand and Arm Function in Persons with De Novo Parkinson’s Disease
Objective: To evaluate hand and arm function and its association with motor symptoms as well as activities of daily living (ADL) in de novo Parkinson's…Does cannabis increase one’s risk for a fall in Parkinson’s disease?: cross-sectional analysis of self-report balance problems and freezing of gait
Objective: To explore the effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on self-report balance problems and freezing of gait (FOG) in Parkinson's disease (PD). Background:…Perceptions of Diseases in Patients with Cervical Dystonia
Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy
Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…Lumbar Punctures in Parkinson’s Research
Objective: This study aims to explore patient perspectives on lumbar punctures for cerebrospinal fluid (CSF) analysis in Parkinson’s disease (PD) research, with the objective of…Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability–Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study
Objective: Evaluate the pharmacokinetics (PK), safety, and tolerability of a once-daily (QD) suvecaltamide (JZP385) formulation and its major active metabolites (JZZ05000034=M01, JZZ05000035=M02) in a Phase…SNCA Antisense Oligonucleotide for Multiple System Atrophy: HORIZON Trial Update
Objective: To provide an update on the baseline demographics and safety from the HORIZON Clinical Trial of ION464 Background: Multiple System Atrophy (MSA) is a…Coordinated Reset Vibrotactile Therapy for the Treatment of Bradykinesia in Parkinson’s Disease Patients
Objective: The present research examines a novel non-invasive vibrotactile device for stimulation of fingertips in a pattern that aims to disrupt pathological physiological beta-band oscillations…
- « Previous Page
- 1
- …
- 171
- 172
- 173
- 174
- 175
- …
- 181
- Next Page »